Table 4 Phase-II regression coefficients of the association of early-life adversity measures with infants’ cytokines and steroids.
Outcome | SES-D | GAD-2 | FAD | CESD-8 | N | R2 | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
B | Std. B | FDR q | B | Std. B | FDR q | B | Std. B | FDR q | B | Std. B | FDR q | |||
TNF-α | 0.00 | −0.01 | 0.935 | 0.08 | 0.19 | 0.216 | 0.01 | 0.04 | 0.352 | −0.01 | −0.10 | 0.320 | 126 | 0.03 |
IL-1β | 0.06 | 0.11 | 0.247 | 0.05 | 0.09 | 0.334 | 0.01 | 0.05 | 0.352 | −0.01 | −0.05 | 0.420 | 126 | 0.02 |
Cortisol | 0.00 | 0.00 | 0.980 | 0.05 | 0.05 | 0.379 | −0.07 | −0.25 | 0.352 | 0.01 | 0.03 | 0.421 | 49 | 0.05 |
Cortisone | −0.04 | −0.08 | 0.562 | −0.05 | −0.09 | 0.334 | −0.01 | −0.09 | 0.352 | 0.07 | 0.39 | 0.035 | 50 | 0.13 |
DHEA | 0.42a | 0.65 | <0.001 | 0.07 | 0.11 | 0.334 | −0.01 | −0.06 | 0.352 | −0.03 | −0.12 | 0.320 | 47 | 0.40 |